Search research articles
Contact Us
Filters
Showing results (91-100 of 151) with videos related to
Page
of 16
Sort By:
Investigational New Drugs
|
August 5, 2010
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma
Simon Pacey, Martin Gore, David Chao, et al.
Anti-Cancer Drugs
|
January 19, 2017
Pazopanib, a promising option for the treatment of aggressive fibromatosis
Zoltan Szucs, Christina Messiou, Han Hsi Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor
Ruth Plummer, Charlotte Rees, Andrew Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Effect of cigarette smoking on imatinib in patients in the soft tissue and bone sarcoma group of the EORTC
Nielka van Erp, Hans Gelderblom, Martine van Glabbeke, et al.
Cancer Chemotherapy and Pharmacology
|
April 10, 2012
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin
Federica Grosso, Maurizio D'Incalci, Mirela Cartoafa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy
Beatrice M Seddon, Geoffrey S Payne, Laura Simmons, et al.
BMC Cancer
|
August 15, 2019
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Axel Le Cesne, Sebastian Bauer, George D Demetri, et al.
Cancer Chemotherapy and Pharmacology
|
January 15, 2008
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models
Udai Banerji, Nivedita Sain, Swee Y Sharp, et al.
Pediatric Blood & Cancer
|
September 25, 2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study
Annemiek M van Maldegem, Charlotte Benson, Piotr Rutkowski, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 22, 2014
Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit
Khurum Khan, Joo Ern Ang, Naureen Starling, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 151) with videos related to
Sort By:
Page
of 16
Investigational New Drugs
|
August 5, 2010
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma
Simon Pacey, Martin Gore, David Chao, et al.
Anti-Cancer Drugs
|
January 19, 2017
Pazopanib, a promising option for the treatment of aggressive fibromatosis
Zoltan Szucs, Christina Messiou, Han Hsi Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor
Ruth Plummer, Charlotte Rees, Andrew Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Effect of cigarette smoking on imatinib in patients in the soft tissue and bone sarcoma group of the EORTC
Nielka van Erp, Hans Gelderblom, Martine van Glabbeke, et al.
Cancer Chemotherapy and Pharmacology
|
April 10, 2012
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin
Federica Grosso, Maurizio D'Incalci, Mirela Cartoafa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy
Beatrice M Seddon, Geoffrey S Payne, Laura Simmons, et al.
BMC Cancer
|
August 15, 2019
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Axel Le Cesne, Sebastian Bauer, George D Demetri, et al.
Cancer Chemotherapy and Pharmacology
|
January 15, 2008
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models
Udai Banerji, Nivedita Sain, Swee Y Sharp, et al.
Pediatric Blood & Cancer
|
September 25, 2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study
Annemiek M van Maldegem, Charlotte Benson, Piotr Rutkowski, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
January 22, 2014
Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit
Khurum Khan, Joo Ern Ang, Naureen Starling, et al.
Page
of 16